Breaking News Instant updates and real-time market news.

EVFM

Evofem

$3.49 /

-0.095 (-2.65%)

08:32
09/08/20
09/08
08:32
09/08/20
08:32

Evofem announces availability of Phexxi in the U.S.

Evofem Biosciences announced that Phexxi, the first and only non-hormonal prescription vaginal gel is now available in the U.S. for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. Approved by the FDA on May 22, Phexxi is a vaginal pH modulator designed to maintain vaginal pH within the normal range of 3.5 to 4.5 - an acidic environment that is inhospitable to sperm. Phexxi will be commercially available in a box containing 12 individually wrapped Phexxi applicators.

  • 03

    Jun

EVFM Evofem
$3.49 /

-0.095 (-2.65%)

08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/10/20 Oppenheimer
Evofem price target raised to $25 from $18 at Oppenheimer
06/09/20 H.C. Wainwright
Evofem price target lowered to $9 from $11 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Technical Analysis
Nasdaq 100 Index: Pivot points » 08:20
09/21/20
09/21
08:20
09/21/20
08:20
NDX

Nasdaq 100 Index

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

NDX Nasdaq 100 Index
$0.00 /

+ (+0.00%)

Hot Stocks
Forum Merger reminds shareholders to vote in favor of extension to Oct. 20 » 08:19
09/21/20
09/21
08:19
09/21/20
08:19
FMCI

Forum Merger

$27.92 /

+0.77 (+2.84%)

Forum Merger II…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMCI Forum Merger
$27.92 /

+0.77 (+2.84%)

FMCI Forum Merger
$27.92 /

+0.77 (+2.84%)

FMCI Forum Merger
$27.92 /

+0.77 (+2.84%)

FMCI Forum Merger
$27.92 /

+0.77 (+2.84%)

Hot Stocks
Liminal BioSciences: FDA confirms receipt of resubmission of BLA for Ryplazim » 08:19
09/21/20
09/21
08:19
09/21/20
08:19
LMNL

Liminal BioSciences

$11.94 /

-0.4 (-3.24%)

Liminal BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMNL Liminal BioSciences
$11.94 /

-0.4 (-3.24%)

Conference/Events
European Association for the Study of Diabetes to hold a virtual annual meeting » 08:19
09/21/20
09/21
08:19
09/21/20
08:19
ABT

Abbott

$106.95 /

+0.21 (+0.20%)

, AMRN

Amarin

$4.18 /

+ (+0.00%)

, AMYT

Amryt Pharma

$12.45 /

-0.35 (-2.73%)

, AZN

AstraZeneca

$56.47 /

+0.53 (+0.95%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DXCM

DexCom

$389.67 /

+3.695 (+0.96%)

, GILD

Gilead

$65.05 /

+0.03 (+0.05%)

, LLY

Eli Lilly

$154.23 /

+1.74 (+1.14%)

, MDT

Medtronic

$107.61 /

-0.26 (-0.24%)

, MRK

Merck

$85.82 /

+0.17 (+0.20%)

, NVO

Novo Nordisk

$69.49 /

-0.05 (-0.07%)

, NVS

Novartis

$90.92 /

+0.07 (+0.08%)

, PODD

Insulet

$224.82 /

+1.08 (+0.48%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$52.42 /

+0.34 (+0.65%)

, TNDM

TNDM

/

+

, VTVT

vTv Therapeutics

$2.07 /

+0.04 (+1.97%)

56th Virtual Annual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$106.95 /

+0.21 (+0.20%)

AMRN Amarin
$4.18 /

+ (+0.00%)

AMYT Amryt Pharma
$12.45 /

-0.35 (-2.73%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

PODD Insulet
$224.82 /

+1.08 (+0.48%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

TNDM TNDM
/

+

VTVT vTv Therapeutics
$2.07 /

+0.04 (+1.97%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
AMRN Amarin
$4.18 /

+ (+0.00%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMYT Amryt Pharma
$12.45 /

-0.35 (-2.73%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital
DXCM DexCom
$389.67 /

+3.695 (+0.96%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
GILD Gilead
$65.05 /

+0.03 (+0.05%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

07:19 Today Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MDT Medtronic
$107.61 /

-0.26 (-0.24%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
MRK Merck
$85.82 /

+0.17 (+0.20%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NVS Novartis
$90.92 /

+0.07 (+0.08%)

09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
09/01/20 Morgan Stanley
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
PODD Insulet
$224.82 /

+1.08 (+0.48%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

06:32 Today H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
SNY Sanofi
$52.42 /

+0.34 (+0.65%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
VTVT vTv Therapeutics
$2.07 /

+0.04 (+1.97%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
ABT Abbott
$106.95 /

+0.21 (+0.20%)

AMRN Amarin
$4.18 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

PODD Insulet
$224.82 /

+1.08 (+0.48%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

TNDM TNDM
/

+

  • 13
    May
ABT Abbott
$106.95 /

+0.21 (+0.20%)

AMRN Amarin
$4.18 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

AMRN Amarin
$4.18 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

PODD Insulet
$224.82 /

+1.08 (+0.48%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

TNDM TNDM
/

+

ABT Abbott
$106.95 /

+0.21 (+0.20%)

AMRN Amarin
$4.18 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

Hot Stocks
Zogenix appoints Caroline Loey, Mary Stutts, Denelle Waynick to board » 08:18
09/21/20
09/21
08:18
09/21/20
08:18
ZGNX

Zogenix

$24.24 /

-0.1 (-0.41%)

, ACHV

Achieve Life Sciences

$10.20 /

-0.8 (-7.27%)

, MYOK

MyoKardia

$136.54 /

+6.4 (+4.92%)

Zogenix (ZGNX) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZGNX Zogenix
$24.24 /

-0.1 (-0.41%)

ACHV Achieve Life Sciences
$10.20 /

-0.8 (-7.27%)

MYOK MyoKardia
$136.54 /

+6.4 (+4.92%)

ZGNX Zogenix
$24.24 /

-0.1 (-0.41%)

08/24/20 Raymond James
Zogenix initiated with a Market Perform at Raymond James
07/15/20 Stifel
Physician survey suggests Zogenix shares undervalued, says Stifel
06/29/20 Mizuho
Zogenix price target lowered to $55 from $64 at Mizuho
06/26/20 Stifel
FDA approval of Fintepla provides 'sigh of relief' for Zogenix, says Stifel
ACHV Achieve Life Sciences
$10.20 /

-0.8 (-7.27%)

09/17/20 Lake Street
Achieve Life Sciences initiated with a Buy at Lake Street
02/25/20 H.C. Wainwright
Achieve Life Sciences initiated with a Buy at H.C. Wainwright
MYOK MyoKardia
$136.54 /

+6.4 (+4.92%)

09/01/20 Cantor Fitzgerald
MyoKardia data looks 'practice changing' for oHCM, says Cantor Fitzgerald
05/20/20 Cantor Fitzgerald
MyoKardia price target raised to $188 from $95 at Cantor Fitzgerald
05/14/20 BMO Capital
MyoKardia price target raised to $148 from $90 at BMO Capital
05/12/20 Citi
MyoKardia takeout value in $160 to $190 per share range, says Citi
ZGNX Zogenix
$24.24 /

-0.1 (-0.41%)

ACHV Achieve Life Sciences
$10.20 /

-0.8 (-7.27%)

MYOK MyoKardia
$136.54 /

+6.4 (+4.92%)

  • 13
    May
  • 04
    Mar
ZGNX Zogenix
$24.24 /

-0.1 (-0.41%)

ZGNX Zogenix
$24.24 /

-0.1 (-0.41%)

MYOK MyoKardia
$136.54 /

+6.4 (+4.92%)

ZGNX Zogenix
$24.24 /

-0.1 (-0.41%)

Recommendations
Upwork price target raised to $19 from $17 at BTIG » 08:17
09/21/20
09/21
08:17
09/21/20
08:17
UPWK

Upwork

$15.34 /

+0.09 (+0.59%)

BTIG analyst Marvin Fong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPWK Upwork
$15.34 /

+0.09 (+0.59%)

UPWK Upwork
$15.34 /

+0.09 (+0.59%)

08/27/20
Upwork started with a Buy at MKM Partners, seen as work-from-home beneficiary
08/26/20 MKM Partners
Upwork initiated with a Buy at MKM Partners
07/01/20 BTIG
Upwork price target raised to $16 from $14 at BTIG
03/19/20 JMP Securities
Upwork price target lowered to $11 from $19 at JMP Securities
UPWK Upwork
$15.34 /

+0.09 (+0.59%)

UPWK Upwork
$15.34 /

+0.09 (+0.59%)

UPWK Upwork
$15.34 /

+0.09 (+0.59%)

UPWK Upwork
$15.34 /

+0.09 (+0.59%)

Hot Stocks
Capstone Turbine gets orders for 10 C65 microturbines, totaling 650 kilowatts, » 08:17
09/21/20
09/21
08:17
09/21/20
08:17
CPST

Capstone Turbine

$4.19 /

-0.03 (-0.71%)

Capstone Turbine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPST Capstone Turbine
$4.19 /

-0.03 (-0.71%)

CPST Capstone Turbine
$4.19 /

-0.03 (-0.71%)

06/30/20 Maxim
Capstone Turbine downgraded to Hold from Buy at Maxim
11/11/19 Lake Street
Capstone Turbine price target lowered to $5 from $30 at Lake Street
11/08/19 Oppenheimer
Capstone Turbine downgraded to Perform from Outperform at Oppenheimer
11/08/19 Oppenheimer
Capstone Turbine downgraded to Perform from Outperform at Oppenheimer
CPST Capstone Turbine
$4.19 /

-0.03 (-0.71%)

Hot Stocks
ATIF Holdings forms strategic collaboration with Zhuhai Boxin Technology » 08:17
09/21/20
09/21
08:17
09/21/20
08:17
ATIF

ATIF Holdings

$1.07 /

+0.02 (+1.90%)

ATIF Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATIF ATIF Holdings
$1.07 /

+0.02 (+1.90%)

Conference/Events
Mizuho to hold a virtual tour » 08:17
09/21/20
09/21
08:17
09/21/20
08:17
CRM

Salesforce

$242.67 /

-1.855 (-0.76%)

2nd Annual Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$242.67 /

-1.855 (-0.76%)

CRM Salesforce
$242.67 /

-1.855 (-0.76%)

09/18/20 Baird
Salesforce benefitting from pandemic ecommerce burst, says Baird
08/26/20 Morgan Stanley
Salesforce price target raised to $275 from $195 at Morgan Stanley
08/26/20 JPMorgan
Salesforce price target raised to $250 from $200 at JPMorgan
08/26/20 Monness Crespi
Salesforce price target raised to $275 from $195 at Monness Crespi
CRM Salesforce
$242.67 /

-1.855 (-0.76%)

CRM Salesforce
$242.67 /

-1.855 (-0.76%)

CRM Salesforce
$242.67 /

-1.855 (-0.76%)

CRM Salesforce
$242.67 /

-1.855 (-0.76%)

Hot Stocks
Enphase Energy announces partnership with three solar distribution companies » 08:15
09/21/20
09/21
08:15
09/21/20
08:15
ENPH

Enphase Energy

$68.30 /

+1.6 (+2.40%)

Enphase Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$68.30 /

+1.6 (+2.40%)

ENPH Enphase Energy
$68.30 /

+1.6 (+2.40%)

08/06/20 H.C. Wainwright
Enphase Energy price target raised to $100 from $48 at H.C. Wainwright
08/05/20 Craig-Hallum
Enphase Energy price target raised to $85 from $54 at Craig-Hallum
08/05/20 Barclays
Enphase Energy price target raised to $90 from $80 at Barclays
08/05/20 Oppenheimer
Enphase Energy price target raised to $77 from $50 at Oppenheimer
ENPH Enphase Energy
$68.30 /

+1.6 (+2.40%)

ENPH Enphase Energy
$68.30 /

+1.6 (+2.40%)

ENPH Enphase Energy
$68.30 /

+1.6 (+2.40%)

ENPH Enphase Energy
$68.30 /

+1.6 (+2.40%)

Hot Stocks
Ashford Hospitality says Cygnus Capital's statements 'misguided and misleading' » 08:15
09/21/20
09/21
08:15
09/21/20
08:15
AHT

Ashford Hospitality

$2.02 /

+0.025 (+1.26%)

Ashford Hospitality Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHT Ashford Hospitality
$2.02 /

+0.025 (+1.26%)

AHT Ashford Hospitality
$2.02 /

+0.025 (+1.26%)

06/17/20
Fly Intel: Top five analyst upgrades
06/17/20 DA Davidson
Ashford Hospitality upgraded to Neutral from Underperform at DA Davidson
04/06/20 B. Riley FBR
Ashford Hospitality downgraded to Neutral from Buy at B. Riley FBR
03/10/20 DA Davidson
Ashford Hospitality downgraded to Underperform from Neutral at DA Davidson
AHT Ashford Hospitality
$2.02 /

+0.025 (+1.26%)

AHT Ashford Hospitality
$2.02 /

+0.025 (+1.26%)

General news
Chicago Fed National Activity Index to be reported at 08:30 » 08:15
09/21/20
09/21
08:15
09/21/20
08:15

August Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Establishment Labs announces publication on hybrid breast reconstruction » 08:14
09/21/20
09/21
08:14
09/21/20
08:14
ESTA

Establishment Labs

$18.66 /

+0.77 (+4.30%)

Establishment Labs…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESTA Establishment Labs
$18.66 /

+0.77 (+4.30%)

ESTA Establishment Labs
$18.66 /

+0.77 (+4.30%)

08/27/20 UBS
Establishment Labs initiated with a Buy at UBS
05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Goldman Sachs
Establishment Labs initiated with a Neutral at Goldman Sachs
01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
ESTA Establishment Labs
$18.66 /

+0.77 (+4.30%)

  • 30
    Jan
Recommendations
Franklin Wireless price target raised to $18 from $16 at Lake Street » 08:13
09/21/20
09/21
08:13
09/21/20
08:13
FKWL

Franklin Wireless

$0.00 /

+ (+0.00%)

Lake Street analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FKWL Franklin Wireless
$0.00 /

+ (+0.00%)

09/15/20 Lake Street
Franklin Wireless initiated with a Buy at Lake Street
Hot Stocks
Teva launches AirDuo Digihaler, ArmonAir Digihaler inhalation powders » 08:13
09/21/20
09/21
08:13
09/21/20
08:13
TEVA

Teva

$9.49 /

+0.19 (+2.04%)

Teva Respiratory,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$9.49 /

+0.19 (+2.04%)

TEVA Teva
$9.49 /

+0.19 (+2.04%)

08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
08/06/20 Barclays
Teva upgraded to Equal Weight on 'stabilizing' fundamentals at Barclays
08/06/20 Barclays
Teva upgraded to Equal Weight from Underweight at Barclays
07/27/20 Goldman Sachs
Teva initiated with a Neutral at Goldman Sachs
TEVA Teva
$9.49 /

+0.19 (+2.04%)

TEVA Teva
$9.49 /

+0.19 (+2.04%)

TEVA Teva
$9.49 /

+0.19 (+2.04%)

TEVA Teva
$9.49 /

+0.19 (+2.04%)

Hot Stocks
Toll Brothers reports preliminary quarter-to-date net signed contracts up 110% » 08:13
09/21/20
09/21
08:13
09/21/20
08:13
TOL

Toll Brothers

$44.74 /

+0.395 (+0.89%)

Toll Brothers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$44.74 /

+0.395 (+0.89%)

TOL Toll Brothers
$44.74 /

+0.395 (+0.89%)

08/27/20 BTIG
Toll Brothers price target raised to $36 from $27 at BTIG
08/27/20 Barclays
Toll Brothers price target raised to $43 from $29 at Barclays
08/26/20 Wedbush
Toll Brothers price target raised to $53 from $45 at Wedbush
08/21/20 Wells Fargo
Toll Brothers price target raised to $44 from $34 at Wells Fargo
TOL Toll Brothers
$44.74 /

+0.395 (+0.89%)

TOL Toll Brothers
$44.74 /

+0.395 (+0.89%)

TOL Toll Brothers
$44.74 /

+0.395 (+0.89%)

TOL Toll Brothers
$44.74 /

+0.395 (+0.89%)

Hot Stocks
Exxon Mobil expands agreement with Global Thermostat » 08:11
09/21/20
09/21
08:11
09/21/20
08:11
XOM

Exxon Mobil

$37.18 /

-0.62 (-1.64%)

ExxonMobil and Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$37.18 /

-0.62 (-1.64%)

XOM Exxon Mobil
$37.18 /

-0.62 (-1.64%)

09/11/20 Standpoint Research
Exxon Mobil upgraded to Buy from Hold at Standpoint Research
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 MKM Partners
Exxon Mobil initiated with a Buy at MKM Partners
09/09/20 MKM Partners
Exxon Mobil initiated with a Buy at MKM Partners
XOM Exxon Mobil
$37.18 /

-0.62 (-1.64%)

XOM Exxon Mobil
$37.18 /

-0.62 (-1.64%)

XOM Exxon Mobil
$37.18 /

-0.62 (-1.64%)

XOM Exxon Mobil
$37.18 /

-0.62 (-1.64%)

Hot Stocks
I-MAB announces China NMPA clearance for Phase 1 trial of lemzoparlimab » 08:11
09/21/20
09/21
08:11
09/21/20
08:11
IMAB

I-MAB

$36.76 /

-1.105 (-2.92%)

I-Mab announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMAB I-MAB
$36.76 /

-1.105 (-2.92%)

IMAB I-MAB
$36.76 /

-1.105 (-2.92%)

09/08/20 Cantor Fitzgerald
I-MAB price target raised to $55 from $50 at Cantor Fitzgerald
07/27/20 Cantor Fitzgerald
I-MAB initiated with an Overweight at Cantor Fitzgerald
02/14/20
Fly Intel: Top five analyst initiations
02/13/20 CICC
I-MAB initiated with an Outperform at CICC
IMAB I-MAB
$36.76 /

-1.105 (-2.92%)

  • 17
    Jan
IMAB I-MAB
$36.76 /

-1.105 (-2.92%)

Hot Stocks
Retrophin enrolls first 280 patients in Phase 3 PROTECT trial of sparsentan » 08:11
09/21/20
09/21
08:11
09/21/20
08:11
RTRX

Retrophin

$20.24 /

+0.57 (+2.90%)

Retrophin announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTRX Retrophin
$20.24 /

+0.57 (+2.90%)

09/17/20 Wedbush
Wedbush starts Retrophin at Outperform ahead of 'value-creating catalysts'
09/17/20 Wedbush
Retrophin initiated with an Outperform at Wedbush
08/24/20 BofA
Retrophin initiated with a Buy at BofA
07/13/20 BMO Capital
Retrophin price target lowered to $31 from $34 at BMO Capital
RTRX Retrophin
$20.24 /

+0.57 (+2.90%)

  • 09
    Jun
Hot Stocks
IPG Photonics discloses detection of ransomware attack » 08:10
09/21/20
09/21
08:10
09/21/20
08:10
IPGP

IPG Photonics

$167.43 /

-1.14 (-0.68%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPGP IPG Photonics
$167.43 /

-1.14 (-0.68%)

IPGP IPG Photonics
$167.43 /

-1.14 (-0.68%)

08/05/20 Citi
IPG Photonics price target raised to $192.90 from $166 at Citi
05/26/20 Raymond James
IPG Photonics downgraded to Outperform from Strong Buy at Raymond James
05/26/20 Raymond James
IPG Photonics downgraded to Outperform from Strong Buy at Raymond James
05/06/20 DA Davidson
IPG Photonics price target raised to $165 from $150 at DA Davidson
IPGP IPG Photonics
$167.43 /

-1.14 (-0.68%)

IPGP IPG Photonics
$167.43 /

-1.14 (-0.68%)

Hot Stocks
Siemens Healthineers announces diagnostic test collaboration with Novartis » 08:10
09/21/20
09/21
08:10
09/21/20
08:10
NVS

Novartis

$90.92 /

+0.07 (+0.08%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

Siemens Healthineers…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$90.92 /

+0.07 (+0.08%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
09/01/20 Morgan Stanley
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

09/04/20 DZ Bank
Siemens Healthineers upgraded to Buy from Hold at DZ Bank
08/18/20 UBS
Siemens Healthineers price target raised to EUR 40 from EUR 39 at UBS
08/12/20 Barclays
Siemens Healthineers price target raised to EUR 40 from EUR 38 at Barclays
08/10/20 BTIG
Varian downgraded to Neutral from Buy at BTIG
NVS Novartis
$90.92 /

+0.07 (+0.08%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

Hot Stocks
Nemaura Medical licenses validated mobile application Healthimation » 08:10
09/21/20
09/21
08:10
09/21/20
08:10
NMRD

Nemaura Medical

$3.84 /

+ (+0.00%)

Nemaura Medical announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMRD Nemaura Medical
$3.84 /

+ (+0.00%)

NMRD Nemaura Medical
$3.84 /

+ (+0.00%)

Hot Stocks
Lipocine announces completion of enrollment in the LPCN 1144 LiFT study » 08:09
09/21/20
09/21
08:09
09/21/20
08:09
LPCN

Lipocine

$1.61 /

+0.105 (+6.98%)

Lipocine announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPCN Lipocine
$1.61 /

+0.105 (+6.98%)

LPCN Lipocine
$1.61 /

+0.105 (+6.98%)

05/27/20 H.C. Wainwright
Lipocine price target raised to $3 from $2 at H.C. Wainwright
11/11/19 H.C. Wainwright
Lipocine price target lowered to $2 from $5 at H.C. Wainwright
11/11/19 Ladenburg
Lipocine downgraded to Neutral from Buy at Ladenburg
LPCN Lipocine
$1.61 /

+0.105 (+6.98%)

  • 14
    Nov
LPCN Lipocine
$1.61 /

+0.105 (+6.98%)

LPCN Lipocine
$1.61 /

+0.105 (+6.98%)

Hot Stocks
Biocept: Highmark makes PCD on Target Selector liquid biopsy assay » 08:08
09/21/20
09/21
08:08
09/21/20
08:08
BIOC

Biocept

$4.46 /

+0.08 (+1.83%)

Biocept announces that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIOC Biocept
$4.46 /

+0.08 (+1.83%)

BIOC Biocept
$4.46 /

+0.08 (+1.83%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
  • 14
    Apr
Hot Stocks
ADT Inc. invests in Percepta Labs security technology startup » 08:08
09/21/20
09/21
08:08
09/21/20
08:08
ADT

ADT Inc.

$8.72 /

-0.44 (-4.80%)

ADT announced that is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADT ADT Inc.
$8.72 /

-0.44 (-4.80%)

ADT ADT Inc.
$8.72 /

-0.44 (-4.80%)

08/10/20 RBC Capital
ADT Inc price target raised to $16 from $10 at RBC Capital
08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
08/03/20 William Blair
Alarm.com downgraded at William Blair on ADT/Google overhang
08/03/20 William Blair
Alarm.com downgraded to Market Perform from Outperform at William Blair
ADT ADT Inc.
$8.72 /

-0.44 (-4.80%)

  • 16
    Sep
ADT ADT Inc.
$8.72 /

-0.44 (-4.80%)

ADT ADT Inc.
$8.72 /

-0.44 (-4.80%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.